RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-8.24%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.44B
AUM Growth
+$3.44B
(-14%)
Cap. Flow
+$132M
Cap. Flow
% of AUM
3.85%
Top 10 Holdings %
Top 10 Hldgs %
35%
Holding
142
New
7
Increased
68
Reduced
12
Closed
10
Top Buys
| 1 |
Align Technology
ALGN
|
$32.7M |
| 2 |
Humana
HUM
|
$27M |
| 3 |
Health Care Select Sector SPDR Fund
XLV
|
$25.6M |
| 4 |
Penumbra
PEN
|
$24.5M |
| 5 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$20.5M |
Top Sells
| 1 |
HCA Healthcare
HCA
|
$94M |
| 2 |
Encompass Health
EHC
|
$35.7M |
| 3 |
iRhythm Technologies
IRTC
|
$17.9M |
| 4 |
XENT
Intersect ENT, Inc
XENT
|
$15.4M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
$14.7M |
Sector Composition
| 1 | Healthcare | 96.7% |
| 2 | Consumer Staples | 0.96% |
| 3 | Industrials | 0.47% |
| 4 | Financials | 0.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
XENT
126
DELISTED
Intersect ENT, Inc
XENT
| – | – |
-550,000
| Closed | -$15.4M |
|
|
PSTX
127
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| – | – |
-289,754
| Closed | -$1.3M |
|
|
LENZ
128
LENZ Therapeutics
LENZ
$1.12B
| – | – |
-1,790,754
| Closed | -$9.13M |
|
129
Shattuck Labs
STTK
$61.3M
| – | – |
-313,499
| Closed | -$1.34M |
|
|
130
Rigel Pharmaceuticals
RIGL
$710M
| – | – |
-4,921,487
| Closed | -$14.7M |
|
|
131
Encompass Health
EHC
$12.5B
| – | – |
-502,500
| Closed | -$35.7M |
|
132
Cullinan Oncology
CGEM
$456M
| – | – |
-652,578
| Closed | -$6.83M |
|
133
Athira Pharma
ATHA
$15.5M
| – | – |
-552,252
| Closed | -$7.46M |
|
|
AMRN
134
Amarin Corp
AMRN
$311M
| – | – |
-4,419,700
| Closed | -$14.5M |
|
|
135
HCA Healthcare
HCA
$95.4B
| – | – |
-375,000
| Closed | -$94M |
|